CJC-1295 (No DAC), GHRP-6 Blend is a synthetic peptide formulation supplied exclusively for controlled laboratory research. CJC-1295 without Drug Affinity Complex is a modified growth hormone-releasing hormone analog. GHRP-6 is a synthetic hexapeptide commonly evaluated in research involving the growth hormone secretagogue receptor type 1a (GHS-R1a).
This blended format may be used for in vitro experimentation, analytical evaluation, receptor-pathway research, assay development, and comparative studies involving separately characterized peptide controls. Experimental work should be conducted by qualified researchers using documented laboratory procedures and suitable control materials.
Lot-specific analytical documentation is available through the NordSci COA Library. Researchers should review the applicable Certificate of Analysis before incorporating the material into an experimental protocol.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
CJC-1295 without DAC is a modified synthetic GHRH analog. The “No DAC” designation identifies a form that does not contain the Drug Affinity Complex modification associated with other CJC-1295 research materials.
GHRP-6 is a synthetic hexapeptide commonly evaluated in laboratory research involving GHS-R1a receptor systems. It may be incorporated into receptor-binding experiments, analytical assays, and controlled pathway studies.
Combining these two materials creates a blended research format for experiments involving both GHRH-receptor and GHS-R1a-receptor systems. Laboratories may compare the blend with individual peptide controls to evaluate assay-specific measurements under predefined experimental conditions.
Individual research materials are also available for CJC-1295 without DAC and GHRP-6.
Important Research Notice: Lot-specific Certificates of Analysis are available for identity, purity, procurement, and research documentation purposes.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR LABORATORY RESEARCH. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR CLINICAL, DIAGNOSTIC, THERAPEUTIC, FOOD, COSMETIC, OR SUPPLEMENT USE.
The blend may be incorporated into controlled laboratory models examining GHRH-receptor and GHS-R1a-receptor pathway measurements across defined sampling intervals. Experimental endpoints should be established before testing and interpreted only within the limitations of the selected assay.
Researchers may use the material in in vitro endocrine-signaling models designed to measure receptor interaction, signal detection, or other predefined laboratory endpoints. Appropriate controls and validated analytical methods are necessary for meaningful interpretation.
Multi-arm laboratory studies may compare the blended material with separately characterized CJC-1295 (No DAC) and GHRP-6 controls. This structure allows researchers to document differences between experimental conditions without attributing findings to human or animal outcomes.
The blend may be evaluated during analytical method development, assay qualification, stability testing, identity assessment, or comparative signal-analysis studies. Researchers should select methods appropriate for the material and intended laboratory endpoint.
Handle CJC-1295 (No DAC), GHRP-6 Blend according to established laboratory procedures for synthetic peptide materials. Laboratories should implement contamination controls, calibrated equipment, appropriate personal protective equipment, and complete chain-of-custody records.
Protocol Design Considerations: Experimental protocols should define material identity, control groups, replicates, sampling intervals, analytical methods, acceptance criteria, and environmental conditions before testing begins. Lot numbers and COA documentation should be recorded with the resulting research data.
This material is supplied only to qualified researchers and laboratory organizations. No dosing, administration, clinical application, or consumption guidance is provided.
Lot-specific Certificates of Analysis document available identity, purity, and quality-control information for the supplied research material. Laboratories should retain the applicable COA with procurement records, study documentation, and experimental data.
Analytical results apply only to the identified lot and should not be generalized to other batches or materials.
NordSci Peptides supplies CJC-1295 (No DAC), GHRP-6 Blend as a laboratory research material with lot-specific analytical documentation. Research organizations should evaluate product identity, COA information, traceability, storage requirements, and institutional procurement standards before purchase.
IMPORTANT: This product is supplied exclusively for laboratory research. It is not approved or intended for human or animal consumption or for clinical, diagnostic, therapeutic, food, cosmetic, or supplement applications.
Researchers should consult current peer-reviewed literature covering synthetic GHRH analogs, GHRH-receptor assay systems, GHS-R1a receptor research, peptide characterization methods, and validated laboratory quality-control practices. The lot-specific Certificate of Analysis should be used as the primary product-level analytical reference.
